GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...

Have a nice week! It’s hard to know exactly what change in Washington will mean for the health care industry starting next ...

Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and ...

LEMSIP and other popular cold and flu tablets should be pulled from Britain’s shelves because they don’t work, experts have ...

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Health Canada has approved the vaccine ... Earlier this week, British drugmaker GSK received approval in Canada for its RSV ...

City-level hospitals purchase 14 large medical appliances, all from leading international companies, at the CIIE on Friday alongside cooperation on infectious disease management.

There’s no better time to be alive, only if we can learn to thrive amidst constant change and disruption” muses health tech ...

Dr. Ingo Behrendt, CEO of Nexus AG, said in a statement that healthcare facilities are increasing their demands ... according ...

With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...